Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Inflamm Bowel Dis. 2023 Dec 5;29(12):1907-1911. doi: 10.1093/ibd/izad039.
Pouchitis occurs in up to 80% of patients after total proctocolectomy (TPC) with ileal pouch-anal anastomosis (IPAA) and has been associated with microbial and host-related immunological factors. We hypothesized that a more robust immune response at the time of colectomy, manifested by acute severe ulcerative colitis (ASUC), may be associated with subsequent acute pouchitis.
This was a retrospective cohort analysis of all patients with UC or indeterminate colitis complicated by medically refractory disease or dysplasia who underwent TPC with IPAA at Mount Sinai Hospital between 2008 and 2017 and at least 1 subsequent pouchoscopy. Acute pouchitis was defined according to the Pouchitis Disease Activity Index. Cox regression was used to assess unadjusted relationships between hypothesized risk factors and acute pouchitis.
A total of 416 patients met inclusion criteria. Of the 165 (39.7%) patients who underwent urgent colectomy, 77 (46.7%) were admitted with ASUC. Acute pouchitis occurred in 228 (54.8%) patients a median of 1.3 (interquartile range, 0.6-3.1) years after the final surgical stage. On multivariable analysis, ASUC (hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.04-2.17) and a greater number of biologics precolectomy (HR, 1.57; 95% CI, 1.06-2.31) were associated with an increased probability of acute pouchitis, while older age at colectomy (HR, 0.98; 95% CI, 0.97-0.99) was associated with a decreased probability. Time to pouchitis was significantly less in patients admitted with ASUC compared with those not (P = .002).
A severe UC disease phenotype at the time of colectomy was associated with an increased probability of acute pouchitis.
全直肠结肠切除(TPC)加回肠贮袋肛管吻合术(IPAA)后, pouchitis 发生率高达 80%,其与微生物和宿主相关免疫因素有关。我们假设在 TPC 时表现为急性重度溃疡性结肠炎(ASUC)的更强免疫反应可能与随后的急性 pouchitis 有关。
这是一项回顾性队列分析,纳入了 2008 年至 2017 年在西奈山医院接受 TPC 加 IPAA 治疗且至少进行了 1 次 pouchoscopy 的 UC 或不确定结肠炎合并药物难治性疾病或异型增生的所有患者。根据 pouchitis 疾病活动指数定义急性 pouchitis。使用 Cox 回归评估假设的危险因素与急性 pouchitis 之间的关系。
共有 416 例患者符合纳入标准。在 165 例(39.7%)接受紧急 TPC 的患者中,77 例(46.7%)因 ASUC 入院。228 例(54.8%)患者在最后手术阶段后中位数 1.3 年(四分位距,0.6-3.1)发生急性 pouchitis。多变量分析显示,ASUC(风险比 [HR],1.50;95%置信区间 [CI],1.04-2.17)和术前接受更多生物制剂(HR,1.57;95% CI,1.06-2.31)与急性 pouchitis 发生的概率增加相关,而 TPC 时年龄较大(HR,0.98;95% CI,0.97-0.99)与发生概率降低相关。与未因 ASUC 入院的患者相比,因 ASUC 入院的患者发生 pouchitis 的时间显著缩短(P =.002)。
在 TPC 时 UC 疾病表型严重与急性 pouchitis 发生的概率增加有关。